glp 1 and kidney stones GLP‑1 medications are becoming more common for diabetes management weight loss, and many patients wonder how they may affect health. Kyle Wood, M.D., MBA, shares insights on current research on GLP-1 receptor agonists and next-generation

How Often Should Glutathione Be Checked

The therapeutic approach to a GO patient should be based on both severity and activity of the disease, the former being the feature to assess first

This review aims to provide an updated overview covering the protective effects of AST against various chronic diseases, including its antioxidant, anti-inflammatory, and anti-apoptotic effects

The acquired form of pyroglutamic acid or 5-oxoproline (PyroGlu) metabolic acidosis was first described in 1989

Practical Prescribing Considerations Starting doses for HRT in the context of GLP-1 use: Transdermal estradiol patch: 0.0375 to 0.05 mg/day, changed twice weekly